Sort
82,697 grants matching “vaccine development”
Defining adaptive immune responses to Mtb-infection and TB disease among young children with and without HIV-exposure
$701,086Christina Louise Lancioni · Oregon Health & Science University · R01 · FY2023 · AI
Immune Function and Biodefense in Children, Elderly, and the Immunocrompromised
$701,080Linda Thompson · Oklahoma Medical Research Foundation · N01 · FY2009 · AI
COVID-19 Vaccinations and School / Community Resources: Children's Longitudinal Health and Education Outcomes Using Linked Administrative Data
$701,037Brian Elbel · New York University School Of Medicine · U01 · FY2022 · NR
Community Outreach and Engagement
$701,030Melissa A. Simon · Northwestern University At Chicago · P30 · FY2025 · CA
Refocusing the Immune Response to the HIV Envelope Glycoprotein
$701,003Phillip Berman · University Of California Santa Cruz · R01 · FY2012 · AI
Immune responses to HIV virus immunization - Project 2
$700,977Margaret Juliana McElrath · Seattle Children'S Hospital · U19 · FY2019 · AI
Biomolecule Production
$700,883Robin A Ross · Harvard Medical School · U54 · FY2011 · AI
Mechanism and Inhibition of Thogotovirus Entry
$700,837Adrianus Cm Boon · Washington University · R01 · FY2025 · AI
Epidemiology of Helicobacter Pylori Transmission
$700,789Julie Parsonnet · Stanford University · R01 · FY2010 · AI
Human Gastrointestinal Biomimetics for Enteric Viral Infections
$700,783Mary Kolb Estes · Baylor College Of Medicine · U19 · FY2023 · AI
Sinusitis in Children and the Nasopharyngeal Microbiome
$700,781Ellen R. Wald · University Of Wisconsin-Madison · R01 · FY2015 · AI
Immune Responses to Vibrio cholerae infection and vaccination in Haiti
$700,752Jason B Harris · Massachusetts General Hospital · R01 · FY2016 · AI
Pilot Project Core
$700,744Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2017 · AI
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
$700,726Mohammad Rashidian · Dana-Farber Cancer Inst · R01 · FY2023 · AI
Multiscale modeling of influenza vaccination strategies for optimal T cell immunity
$700,715Jacob E Kohlmeier · Emory University · U01 · FY2019 · HL
SERCEB Individual Career Development Support Program
$700,680Philip Frederick Sparling · Univ Of North Carolina Chapel Hill · U54 · FY2013 · AI
The COVID-19 and Cancer Consortium (CCC19) Registry
$700,645Jeremy Lyle Warner · Rhode Island Hospital · U01 · FY2025 · CA
HIV-1 vaccine-elicited antibodies target envelope glycans
$700,558Kevin O Saunders · Duke University · R01 · FY2019 · AI
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
$700,557David A. Rosen · Washington University · R01 · FY2024 · AI
IgM in the regulation of TB immunity
$700,549John R. Chan · Albert Einstein College Of Medicine · R01 · FY2019 · AI
Membrane-based vaccine with checkpoint blockade for triple negative breast cancer
$700,539Kamal V. Kannan · Metaclipse Therapeutics Corporation · R44 · FY2017 · CA
The Epigenetic Enzyme CARM1 as a Negative Regulator of Dendritic cells and CD8 T cells in Melanoma
$700,514Kai W Wucherpfennig · Massachusetts General Hospital · P01 · FY2024 · CA
Mechanisms of Antibody-Mediated Neutralization of Flavirus Infection
$700,493Theodore C Pierson · Niaid Extramural Activities · Z01 · FY2007 · AI
Development of Novel mRNA Vaccines Against Mycobacterium tuberculosis
$700,469Thomas Siegmund Postler · International Aids Vaccine Initiative · R33 · FY2025 · AI
Human Antibodies and Targeted Vaccines Against SARS-CoV
$700,465Wayne A. Marasco · Dana-Farber Cancer Inst · U01 · FY2007 · AI